A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2002
12/10/2002	US6491952 Beta-sitosterol and/or beta-sitostanol in a monomolecular, low associated or ?cluster? form, melt and/or solution; foods
12/10/2002	US6491951 Soluble compositions of toremifene
12/10/2002	US6491950 High melting point fatty acid ester, an oil, hydroxypropyl ether cellulose or a methyl ether cellulolse, polysorbate 80 surfactant; hard shell capsule
12/10/2002	US6491949 First osmotic device enclosed within a second osmotic device; semipermeable membrane dissolves or degrades during use; delivery of active agents over a prolonged and extended period of time; tablets
12/10/2002	US6491948 Increased bioavailability; preventing oxidative destabilization of dnas, rnas and proteins involved in neuronal memory processes;neuroprotective agents possessing preventive properties against memory dysfunctions
12/10/2002	US6491947 Expanded perborate salt, use, and method of production
12/10/2002	US6491946 Potassium iodide, microcrystalline cellulose, hydroxypropyl methylcellulose and/or gelatin as binder; formation of iodine is surprisingly suppressed without antioxidants being present
12/10/2002	US6491945 Alkali carboxymethylcellulose, hydroxypropylalkylcellulose and a lubricant
12/10/2002	US6491944 Method for making spirillicide
12/10/2002	US6491943 Method for treating an allergic or inflammatory disease
12/10/2002	US6491942 Hydrophobic hydroxypropyl methylcellulose having a long chain alkyloxyhydroxypropoxyl group, alkyl is a straight or branched chain alkyl having 6 to 26 carbon atoms
12/10/2002	US6491939 Pharmacotherapeutic process and composition for central nervous system disorders
12/10/2002	US6491938 Prevent restenosis after vascular system trauma
12/10/2002	US6491936 Creams containing vitamin D3 derivatives
12/10/2002	US6491919 Attenuated lipid and surfactant in aqueous solution
12/10/2002	US6491904 Topical composition containing human epidermal growth factor
12/10/2002	US6491903 Particles comprising amphiphilic copolymers
12/10/2002	US6491900 Containing calcium phosphate; remineralization of teeth
12/10/2002	US6491897 Solvent mixtures of water, ethanol and optionally isopropanol, propylene glycol and/or disodium ethylenediaminetetraacetate, containing drugs, used in inhalants; shelf life
12/10/2002	US6491684 Fluid delivery device having a water generating electrochemical/chemical pump and associated method
12/10/2002	US6491683 Osmotic dosage form composed of an extruded polymer tube form
12/10/2002	US6491666 Microfabricated devices for the delivery of molecules into a carrier fluid
12/10/2002	US6491663 Medical devices using electrosensitive gels
12/10/2002	US6491619 Radiation delivery catheters and dosimetry methods
12/10/2002	US6491540 Chewing gum consisting of guarana with a liquid filled center containing dietary supplement, metabolic enhancer, plant extract etc.
12/10/2002	CA2201967C Acetamide derivative having defined particle size
12/10/2002	CA2094533C Hydrocolloid wound gel
12/10/2002	CA2093431C Ionically cross-linked polymeric microcapsules
12/10/2002	CA2074580C Solid pharmaceutical composition for oral administration containing dapiprazole
12/09/2002	CA2411950A1 Patch
12/08/2002	CA2392486A1 Pharmaceutical dosage form bearing pregnancy-friendly indicia
12/07/2002	CA2349989A1 Bioactive surface modifiers for polymers and articles made therefrom
12/06/2002	WO2002039982A1 Oral formulations for localized colonic release and the method of preparation thereof
12/06/2002	CA2411045A1 Oral formulations for localized colonic release and the method of preparation thereof
12/05/2002	WO2002097116A2 Delivery system for nucleic acids
12/05/2002	WO2002097054A2 Shaped microcomponents via reactive conversion of biologically-derived microtemplates
12/05/2002	WO2002097044A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities
12/05/2002	WO2002096927A2 Ribozyme based treatment of female reproductive diseases
12/05/2002	WO2002096551A1 Dissolvable nanocapsules and microcapsules, method for the production thereof and their use
12/05/2002	WO2002096496A1 Embolic devices capable of in-situ reinforcement
12/05/2002	WO2002096466A1 Medicinal composition
12/05/2002	WO2002096464A1 Nucleotide compounds that block the bitter taste of oral compositions
12/05/2002	WO2002096457A2 Stable liquid formulations of antibodies
12/05/2002	WO2002096449A1 Carbohydrate modifying agent and drinks containing the modifying agent
12/05/2002	WO2002096447A2 Pharmaceutical preparation containing active ingredients extracted from the plants centella asiatica, mahonia aquifolium and viola tricolor
12/05/2002	WO2002096438A1 Synergistic antibiotic compositions
12/05/2002	WO2002096435A2 Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor a monohydric alcohol
12/05/2002	WO2002096434A1 Plaster preparation
12/05/2002	WO2002096433A1 Methods for treating delirium using glucocorticoid receptor-specific antagonists
12/05/2002	WO2002096429A1 Agent for external therapy of psoriasis and method for producing said agent
12/05/2002	WO2002096423A2 Combination of a pde4 inhibitor and tiotropium or derivate thereof for treating obstructive airways
12/05/2002	WO2002096422A2 Combination of a dopamine d2-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways
12/05/2002	WO2002096418A1 Pirenzepine ophthalmic gel
12/05/2002	WO2002096407A1 Liquid drug preparations
12/05/2002	WO2002096406A1 Medicinal compositions
12/05/2002	WO2002096405A1 Drug preparations
12/05/2002	WO2002096404A1 Method of treating gastroesophageal reflux disease and nocturnal acid breakthrough
12/05/2002	WO2002096401A1 Solid pharmaceutical formulations comprising modafinil
12/05/2002	WO2002096396A1 Fine inorganic particles having drug included therein, method for preparation thereof and pharmaceutical preparation comprising fine inorganic particles having drug included therein
12/05/2002	WO2002096395A1 Soft elastic capsules comprising ritonavir and/or lopinavir
12/05/2002	WO2002096392A1 Taste-masking of highly water-soluble drugs
12/05/2002	WO2002096391A1 Foamed sol-gel and method of manufacturing the same
12/05/2002	WO2002096390A1 Neutral-cationic lipid for systemic delivery of factor viii gene
12/05/2002	WO2002096389A1 Conformal coated microchip reservoir devices
12/05/2002	WO2002096388A1 Surface roughness quantification of pharmaceutical, herbal, nutritional dosage forms and cosmetic preparations
12/05/2002	WO2002096387A1 Implantable medical device with controllable gaseous agent release system
12/05/2002	WO2002096386A1 Solid form immunity adjuvant and vaccine containing same
12/05/2002	WO2002096380A1 Aerosol composition comprising silicate particles and surfactants
12/05/2002	WO2002096379A1 Aerosol composition comprising silicate particles and polymers
12/05/2002	WO2002096374A2 Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
12/05/2002	WO2002096370A1 Pack based on water-soluble nonwoven fabric
12/05/2002	WO2002096368A2 Encapsulation of nanosuspensions in liposomes and microspheres
12/05/2002	WO2002096367A2 Targeted multivalent macromolecules
12/05/2002	WO2002096354A2 Enhancement of oral bioavailability of non-emulsified formulation of prodrug esters with lecithin
12/05/2002	WO2002096347A2 Metering and packaging of controlled release medication
12/05/2002	WO2002096224A1 Oral composition comprising an extract from the bark of albizzia myriophylla
12/05/2002	WO2002074247A3 Pharmaceutical formulations for sustained release
12/05/2002	WO2002066009A9 Modulated release particles for aerosol delivery
12/05/2002	WO2002065978A3 Functional agent for decomposing nicotine and method of preparing the same
12/05/2002	WO2002064189A3 Radiation cross-linked hydrogels
12/05/2002	WO2002064124A3 Medicament formulation containing a muscarinic agonist
12/05/2002	WO2002060417A8 Binding agent which is stable in storage and used for pharmaceutical applications
12/05/2002	WO2002058678A3 Devices and methods for heat-pulse assisted thermal applications of active substances
12/05/2002	WO2002049619A3 Induced phase transition method for the production of microparticles containing hydrophilic active agents
12/05/2002	WO2002049571A3 Personal medication dispensing card
12/05/2002	WO2002036073A3 Receptor antagonist-lipid conjugates and delivery vehicles containing same
12/05/2002	WO2002034234A3 Methylphenidate modified release formulations
12/05/2002	WO2002022106A3 Stable ophthalmic preparation
12/05/2002	WO2002009637A3 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
12/05/2002	WO2001045577A9 Intervertebral disc treatment devices and methods
12/05/2002	WO2001019408A9 Nucleic acids encoding polyepitope polypeptides
12/05/2002	US20020183764 Embolic materials
12/05/2002	US20020183722 Implantable osmotic pump
12/05/2002	US20020183721 Microchip devices with improved reservoir opening
12/05/2002	US20020183683 Methods and apparatus for enhanced and controlled delivery of a biologically active agent into the central nervous system of a mammal
12/05/2002	US20020183394 Pharmaceutical compositions of fenretinide having increased bioavailability and methods of using the same
12/05/2002	US20020183392 Inhibiting oxidative degradation of pharmaceutical formulations
12/05/2002	US20020183385 Administering a therapeutically effective amount of arsenic compounds to a mammal for treating solid tumor
12/05/2002	US20020183380 Administering anti-microtubule compound-containing, pharmaceutically acceptable formulation wherein anti-microtubule compound is paclitaxel for therapy and prophylaxis of surgical adhesions
12/05/2002	US20020183378 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

1 ... 2203 2204 2205 2206 2207 2208 2209 2210 2211 2212 2213 2214 2215 2216 2217 2218 2219 2220 2221 2222 2223 ... 2991